Cover Image

Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers.

Fuente: PubMed

Saved in:

Bibliographic Details
Main Authors:	Cogoluegnes, Sarah, Kovachka, Sandra, Dubois, Thierry, Würth, Roberto, Donato, Elisa, Trumpp, Andreas, Franco, Michel, Luton, Frédéric, Azoulay, Stéphane, Mus-Veteau, Isabelle
Format:	Artículo científico
Language:	en
Published:	Translational oncology 2026
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Photodynamic priming modulates cellular ATP levels to overcome P‐glycoprotein‐mediated drug efflux in chemoresistant triple‐negative breast cancer
by: Idrisa Rahman, et al.
Published: (2024)

Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors
by: Tomomi Nishimura, et al.
Published: (2024)

Adding carboplatin to adjuvant chemotherapy improved survival in early‐stage triple‐negative breast cancer
by: Leah Lawrence
Published: (2026)

Exploration of the sensitization effect of Chaihu Shugan powder on chemotherapy for triple‐negative breast cancer and its active ingredients
by: Wei Wei, et al.
Published: (2024)

Dietary influences on chemotherapy sensitivity and cardiotoxicity modulated by IRE1 targeting in triple‐negative breast cancer in female mice
by: Yismeilin R. Feliz‐Mosquea, et al.
Published: (2025)

Targeting c‐Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple‐negative breast cancer
by: Xiaojie Liang, et al.
Published: (2025)

Section 2 Particle Dynamics Across the ∇τ.pdf
by: Keith Luton
Published: (2024)

Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer
by: Fan‐Wei Yang, et al.
Published: (2024)

Isobavachalcone, a natural sirtuin 2 inhibitor, exhibits anti‐triple‐negative breast cancer efficacy in vitro and in vivo
by: Ya‐li Ren, et al.
Published: (2024)

Use of chemotherapy and loco‐regional therapy in stage IA triple‐negative breast cancer and their association with oncologic outcomes: A cancer registry study
by: André Pfob, et al.
Published: (2024)

Radiological diagnostics of triple negative breast cancer: a review
by: Sigutė Stadalnykaitė
Published: (2011)

Phytochemical Investigation of an Ostrya carpinifolia L. Extract: An Effective Anti‐Pollution Cosmetic Active Ingredient.
by: Manon Trinel, et al.
Published: (2024)

Results from the grant "Adoptive nanotherapy against ATF4 in triple negative breast cancer patients-derived models"
by: Sergio Granados-Principal, et al.
Published: (2025)

Therapeutic targeting in androgen receptor-negative triple negative breast cancer (AR- TNBC): HUNK.
by: Mamoor, Shahan
Published: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)

Multi‐omic analysis of dysregulated pathways in triple negative breast cancer
by: Fatima Sajjad, et al.
Published: (2024)

Guideline concordance in triple‐negative breast cancer: What does it measure?
by: Jennifer L. Caswell‐Jin, et al.
Published: (2026)

Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple‐negative breast cancer: Results from the triple‐negative breast cancer cohort of the phase 2 LEAP‐005 Study
by: Hyun Cheol Chung, et al.
Published: (2024)

PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis
by: Song Wang, et al.
Published: (2024)

Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
by: Yuechen Wang, et al.
Published: (2024)

SAA1‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness
by: Ilona Rybinska, et al.
Published: (2024)

Electroporation-mediated Metformin for effective anticancer treatment of triple-negative breast cancer cells
by: Sahu, Praveen, et al.
Published: (2024)

Metastatic triple‐negative breast carcinoma mimicking melanoma: A potential diagnostic pitfall
by: Rebecca Fliorent, et al.
Published: (2024)

Correction to “The SWI/SNF ATPases are required for triple negative breast cancer cell proliferation”
Published: (2024)

Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis
by: Joseph Lipscomb, et al.
Published: (2026)

Avaliação psicológica no adolescente: objeto de mediação terapêutica
by: Catherine Azoulay
Published: (2012)

TRAIL ‐ PEG ‐Apt‐ PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model
by: Gulen Melike Demirbolat, et al.
Published: (2026)

PASSIVE (RE)TRANSLATIONS AND IDENTITY STRUGGLES IN THE POETRY OF LEONARD COHEN. A COMPARISON OF THREE TRANSLATIONS OF BOOK OF LONGING (2006)
by: Francis Mus
Published: (2019)

Cyclin‐dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple‐negative breast cancer by affecting the immune microenvironment
by: Jiayi Wu, et al.
Published: (2024)

Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
by: Mamoor, Shahan
Published: (2025)

HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer
by: Xue Yang, et al.
Published: (2024)

SBFI26 induces triple‐negative breast cancer cells ferroptosis via lipid peroxidation
by: Gang He, et al.
Published: (2024)

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer
by: Nur Aininie Yusoh, et al.
Published: (2025)

Siglec15/ TGF ‐β bispecific antibody mediates synergistic anti‐tumor response against 4T1 triple negative breast cancer in mice
by: Limei Shen, et al.
Published: (2024)

Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models
by: Nino Giunashvili, et al.
Published: (2024)

Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
by: Mamoor, Shahan
Published: (2025)

89Zr‐Labeled DFO@Durvalumab‐HSA nanoparticles: In vitro potential for triple‐negative breast cancer
by: Fatma Yurt, et al.
Published: (2024)

Tristetraprolin affects invasion‐associated genes expression and cell motility in triple‐negative breast cancer model
by: Anastasiia Hubiernatorova, et al.
Published: (2024)